Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001161697-15-000430
Filing Date
2015-10-09
Accepted
2015-10-09 16:06:00
Documents
1
Period of Report
2015-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 3/A form_3.html 3/A  
1 FORM 3/A form_3.xml 3/A 5436
  Complete submission text file 0001161697-15-000430.txt   7059
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address
Merrigan Paul J (Reporting) CIK: 0001653275 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33057 | Film No.: 151153219